User profiles for P. Cacoub

Patrice Cacoub

Sorbonne Université, Paris 6
Verified email at aphp.fr
Cited by 72501

The DRESS syndrome: a literature review

P Cacoub, P Musette, V Descamps, O Meyer… - The American journal of …, 2011 - Elsevier
The Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) is a severe adverse
drug-induced reaction. Diagnosing DRESS is challenging due to the diversity of cutaneous …

Iron deficiency anaemia

A Lopez, P Cacoub, IC Macdougall, L Peyrin-Biroulet - The Lancet, 2016 - thelancet.com
Anaemia affects roughly a third of the world's population; half the cases are due to iron
deficiency. It is a major and global public health problem that affects maternal and child mortality, …

Erdheim-Chester disease clinical and radiologic characteristics of 59 cases

C Veyssier-Belot, P Cacoub, D Caparros-Lefebvre… - Medicine, 1996 - journals.lww.com
… CATHERINE VEYssER-BELOT, MD, PATRICE CACoUB, MD, DoMINIqUE CAPARRos-…
P. Cacoub, Service de médecine interne, hôpital Pitié-Salpêtrière, 47-83 Bd de l'hôpital, …

[HTML][HTML] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

…, HR Black, WE Boden, P Cacoub… - … England Journal of …, 2006 - Mass Medical Soc
Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been
studied in a broad population of patients at high risk for atherothrombotic events. Methods We …

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]

…, P Cacoub, D Cazals-Hatem, P Babinet… - 1995 - ashpublications.org
Multicentric Castleman's disease (MCD) is an atypical lymphoproliferative disorder defined
using clinical and pathologic criteria. A characteristic of the MCD is a close association with …

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

…, PB Berger, HR Black, WE Boden, P Cacoub… - Journal of the American …, 2007 - jacc.org
Objectives : The purpose of this study was to determine the possible benefit of dual antiplatelet
therapy in patients with prior myocardial infarction (MI), ischemic stroke, or symptomatic …

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported …

…, J Bachiller-Corral, S Bhana, P Cacoub… - Annals of the …, 2021 - ard.bmj.com
Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

…, L Piroth, D Salmon-Céron, C Degott, P Cacoub… - Jama, 2004 - jamanetwork.com
… Bristol-Myers Squibb, GlaxoSmithKline, and Gilead; Dr Pialoux has received a grant from
Aventis; Dr Degott has served as a consultant for Roche and Schering-Plough; and Dr Cacoub

Extrahepatic manifestations of chronic hepatitis C

P Cacoub, T Poynard, P Ghillani… - … : Official Journal of …, 1999 - Wiley Online Library
… Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with
chronic hepatitis C: the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;…

[HTML][HTML] Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

…, B Delmas, F Valensi, P Cacoub… - … England Journal of …, 2002 - Mass Medical Soc
Background Some epidemiologic studies suggest a link between hepatitis C virus (HCV)
infection and some B-cell non-Hodgkin's lymphomas. We undertook this study after a patient …